Humanoid Global Reports Progress on Cartwheel Robotics' Flagship Humanoid Yogi

The most recent news, dated October 16, 2025, from Humanoid Global Holdings Corp. (ROBO), reports significant progress on Cartwheel Robotics Inc.'s flagship humanoid embodied AI platform, "Yogi." Key updates include: * Development Progress: Cartwheel Robotics is actively developing a proprietary full-stack humanoid platform, integrating custom hardware, AI models, motion systems, and software. Yogi is designed for natural movement, intuitive response, and an approachable presence, featuring medical-grade silicone, protective soft materials, precision-engineered high-torque actuators, overload protection, and a modular, swappable battery system. * Market Exploration: Preliminary discussions are underway with a leading North American medical institution for a potential co-development project and pilot in healthcare applications. Additionally, Cartwheel has received letters of interest from several North American universities for research and testing collaborations. * Infrastructure Expansion: Construction of Cartwheel Robotics' Oddie facility in Reno, Nevada, is underway, with an expected completion date of January 2026. * Upcoming Milestone: A full-body walking prototype of Yogi is targeted for debut in December 2025 at the Humanoid Summit. * Financing Initiative: Cartwheel Robotics has initiated a seed financing round to fund engineering, hardware production, and continued full-stack development.

This news provides a positive update on one of Humanoid Global's key portfolio companies, Cartwheel Robotics. The progress on Yogi's development, the exploration of healthcare applications, and the expressions of interest from universities indicate potential for future commercialization and validation of the technology. The establishment of a new facility also suggests a commitment to scaling operations.

However, the impact is assessed as "Routine - Positive" rather than "Material" for several reasons: 1. Future Milestones: The key milestone, the full-body walking prototype, is targeted for December 2025. This is a future event, not an immediate achievement. 2. Financing Needs: The initiation of a seed financing round for Cartwheel indicates ongoing capital requirements at the portfolio level, which aligns with Humanoid Global's own recently announced $2.0 million financing. While essential for growth, it underscores continuous dilution risk for Humanoid Global shareholders if ROBO needs to participate or if successful raises by portfolio companies don't significantly boost ROBO's valuation. 3. Preliminary Discussions: The discussions with a medical institution and universities are preliminary ("exploring," "received letters of interest"). These are positive signals but are not binding agreements or secured revenue streams. 4. Context of Prior News: This news follows a series of positive, but mostly incremental, developments (RideScan patent/pilots, Apptronik investment, advisory board addition, and the crucial $2M capital raise). This latest update confirms that work is progressing as expected within the portfolio. It does not introduce a game-changing new product or a definitive major commercial deal.

The news provides confidence that Cartwheel Robotics is actively executing its development plan and exploring market opportunities. While positive, it largely aligns with the expected trajectory of an early-stage robotics company and does not significantly alter the immediate risk/reward profile of Humanoid Global beyond what the market has already factored in from the recent capital raise and general sentiment.

Humanoid Global Holdings Corp. (CSE: ROBO, FWB: 0XM1, OTCQB: RBOHF) positions itself as an investment holding company focused on the rapidly evolving humanoid robotics and embodied AI landscape. Its strategy involves funding and supporting companies that are developing the next generation of intelligent automation.

ROBO's portfolio includes: * Cartwheel Robotics Inc. (Flagship Project: Yogi): Yogi is an embodied AI platform designed to move naturally, respond intuitively, and bring a lifelike presence to everyday environments. It features medical-grade silicone, protective soft materials, high-torque actuators, and a modular battery system. Cartwheel is developing a full-stack humanoid platform and exploring applications in healthcare and research. A full-body walking prototype is expected in December 2025. * RideScan Ltd.: This subsidiary specializes in independent risk scoring and anomaly detection in robotics. Its technology aims to enhance operational safety and reliability, reduce downtime, and uncover hidden anomalies. RideScan has filed a foundational patent in the UK, initiated pilot deployments, and secured grant funding and angel investment for commercialization. * Apptronik Inc. (Flagship Product: Apollo): Humanoid Global has committed to an indirect strategic investment in Apptronik, a human-centered robotics company. Apptronik's flagship product, Apollo, is an award-winning humanoid robot designed for human-robot collaboration across various applications, including manufacturing, logistics, retail, healthcare, and home use.

The company's overall "flagship project" is effectively its entire portfolio of investments, with Cartwheel Robotics' Yogi and Apptronik's Apollo representing significant potential in the humanoid robot space.